Songy B, Guernou M, Hivoux D, Attias D, Lussato D, Queneau M, Bonardel G, Bertaux M. Prognostic value of one millisievert exercise myocardial perfusion imaging in patients without known coronary artery disease.
J Nucl Cardiol 2018;
25:120-130. [PMID:
27506702 DOI:
10.1007/s12350-016-0601-5]
[Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2016] [Accepted: 07/06/2016] [Indexed: 10/21/2022]
Abstract
The aim of this study was to assess the prognostic value of normal ultra-low-dose exercise MPI with a CZT camera.
METHODS
1901 consecutive patients without known CAD referred for exercise MPI with 1.8 MBq/kg (0.05 mCi) of Tc99m sestamibi or tetrofosmin and a CZT camera were included prospectively. Patients with an abnormal scan requiring an additional resting image (230) or a submaximal exercise test (271) were excluded. The 1400 remaining patients were followed for 39 months. The primary end-point was cardiac events (cardiac death, nonfatal myocardial infarction, and revascularization). The secondary end-point was noncardiac death.
RESULTS
The mean injected activity was 145 ± 37 MBq (3.9 ± 1 mCi), the mean acquisition duration was 10 ± 0.7 minutes, and the mean effective dose was 0.91 ± 0.13 mSv. 1288 patients (92%) achieved full follow-up. We observed 22 cardiac events and 16 noncardiac deaths. The annualized rates were equivalent to 0.55% for cardiac events and 0.37% for noncardiac mortality.
CONCLUSIONS
Normal ultra-low-dose exercise MPI with a CZT camera has a high negative predictive value. The effective dose was less than 1 mSv, and the study thus allays concerns about radiation burden.
Collapse